Deepak Voora
Deepak Voora
Department of Veterans Affairs; Duke University Medical Center
Dirección de correo verificada de
Citado por
Citado por
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
D Voora, SH Shah, I Spasojevic, S Ali, CR Reed, BA Salisbury, ...
Journal of the American college of cardiology 54 (17), 1609-1616, 2009
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update
LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ...
Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014
The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy
RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ...
Clinical Pharmacology & Therapeutics 92 (1), 112-117, 2012
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ...
JACC: Cardiovascular Interventions 11 (2), 181-191, 2018
Phenotype standardization for statin‐induced myotoxicity
A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ...
Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
D Voora, C Eby, MW Linder, PE Milligan, BL Bukaveckas, HL McLeod, ...
Thrombosis and haemostasis 93 (04), 700-705, 2005
Genetic-based dosing in orthopedic patients beginning warfarin therapy
EA Millican, PA Lenzini, PE Milligan, L Grosso, C Eby, E Deych, G Grice, ...
Blood, The Journal of the American Society of Hematology 110 (5), 1511-1515, 2007
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal …
RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ...
Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
C Varenhorst, N Eriksson, A Johansson, BJ Barratt, E Hagström, ...
European heart journal 36 (29), 1901-1912, 2015
A host-based RT-PCR gene expression signature to identify acute respiratory viral infection
AK Zaas, T Burke, M Chen, M McClain, B Nicholson, T Veldman, EL Tsalik, ...
Science translational medicine 5 (203), 203ra126-203ra126, 2013
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans
D Voora, DC Koboldt, CR King, PA Lenzini, CS Eby, R Porche‐Sorbet, ...
Clinical Pharmacology & Therapeutics 87 (4), 445-451, 2010
The pharmacogenetics of coumarin therapy
D Voora, HL McLeod, C Eby, BF Gage
Pharmacogenomics 6 (5), 503-513, 2005
Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response
D Voora, SH Shah, CR Reed, J Zhai, DR Crosslin, C Messer, ...
Circulation: Cardiovascular Genetics 1 (2), 100-106, 2008
Clinical application of cardiovascular pharmacogenetics
D Voora, GS Ginsburg
Journal of the American College of Cardiology 60 (1), 9-20, 2012
The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting
LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ...
Clinical and translational science 10 (3), 143, 2017
Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME care randomized clinical …
DW Oslin, KG Lynch, MC Shih, EP Ingram, LO Wray, SR Chapman, ...
Jama 328 (2), 151-161, 2022
Platelets amplify endotheliopathy in COVID-19
TJ Barrett, MI Cornwell, K Myndzar, CC Rolling, Y Xia, K Drenkova, ...
Science Advances 7 (37), eabh2434, 2021
Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter‐directed atrial fibrillation ablation
TW Wallace, BD Atwater, JP Daubert, D Voora, AL Crowley, TD Bahnson, ...
Journal of cardiovascular electrophysiology 21 (8), 849-852, 2010
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events
D Voora, D Cyr, J Lucas, JT Chi, J Dungan, TA McCaffrey, R Katz, ...
Journal of the American College of Cardiology 62 (14), 1267-1276, 2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20